KeyBanc analyst Donald Hooker raised his price target for Teladoc (TDOC) to $90 form $74 after hosting a series of investor meetings with management. The analyst sees upside to consensus estimates in 2019 and 2020 given the company’s progress achieving synergies from recent acquisitions and signs of momentum with its multimedia member engagement strategy. Hooker also sees emerging accelerants to growth, including pending RFPs with UnitedHealth Group (UNH) and new opportunities in Medicare Advantage. He reiterates an Overweight rating on Teladoc’s shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.